Share on Pinterest MIT engineers have developed a small implantable device that could help people with type 1 diabetes monitor their glucose levels. RichLegg/Getty Images Engineers at MIT say they ...
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback